Transcriptome analysis of human autosomal trisomy

Human Molecular Genetics

Volumn 11, Issue 26, 2002, Pages 3249-3256

  FitzPatrick, David R ^a   Ramsay, Jacqueline ^a   McGill, Niolette I ^a   Shade, Mary ^b   Carothers, Andrew D ^a   Hastie, Nicholas D ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b WGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ANEUPLOIDY; ARTICLE; CELL CULTURE; CHROMOSOME ANALYSIS; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISEASE SEVERITY; DNA MICROARRAY; FETUS CELL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KARYOTYPE; KARYOTYPING; PHENOTYPE; PREGNANCY DISORDER; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TRISOMY 13; TRISOMY 21; UPREGULATION;

CHROMOSOMES, HUMAN, PAIR 13; DOWN SYNDROME; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRISOMY; UP-REGULATION;

EUKARYOTA;

EID: 0037115492     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.26.3249     Document Type: Article

References (34)

1. Hassold, T., Hunt, P.A. and Sherman, S. (1993) Trisomy in humans: incidence, origin and etiology. Curr. Opin. Genet. Dev., 3, 398-403.
2. Kalter, H. and Warkany, J. (1983) Medical progress. Congenital malformations: etiologic factors and their role in prevention (first of two parts). N. Engl. J. Med., 308, 424-431.
3. Carothers, A.D. (1994) A cytogenetic register of trisomies in Scotland: results of the first 2 years (1989, 1990). Clin. Genet., 46, 405-409.
4. Kurnit, D.M. (1979) Down syndrome: gene dosage at the transcriptional level in skin fibroblasts. Proc. Natl Acad. Sci. USA, 76, 2372-2375.
5. Newby, D., Aitken, D.A., Crossley, J.A., Howatson, A.G., Macri, J.N. and Connor, J.M. (1997) Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies. Prenat. Diagn., 17, 941-951.
6. Hackshaw, A.K. and Wald, N.J. (2000) Revised distribution parameters for serum markers for trisomy 18. J. Med. Screen., 7, 215.
7. Aitken, D.A., McCaw, G., Crossley, J.A., Berry, E., Connor, J.M., Spencer, K. and Macri, J.N. (1993) First-trimester biochemical screening for fetal chromosome abnormalities and neural tube defects. Prenat. Diagn., 13, 681-689.
8. Moghadam, S., Engel, W., Bougoussa, M., Hennen, G., Igout, A. and Sancken, U. (1998) Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: implications for prenatal diagnosis of trisomy 21. Fetal Diagn. Ther., 13, 291-297.
9. Anneren, G., Tuvemo, T., Carlsson-Skwirut, C., Lonnerholm, T., Bang, P., Sara, V.R. and Gustafsson, J. (1999) Growth hormone treatment in young children with Down's syndrome: effects on growth and psychomotor development. Arch. Dis. Child., 80, 334-338.
10. Pollack, J.R., Perou, C.M., Alizadeh, A.A., Eisen, M.B., Pergamenschikov, A., Williams, C.F., Jeffrey, S.S., Botstein, D. and Brown, P.O. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet., 23, 41-46.
11. Brewer, C., Holloway, S., Zawalnyski, P., Schinzel, A. and FitzPatrick, D. (1999) A chromosomal duplication map of malformations: regions of suspected haplo- and triplolethality-and tolerance of segmental aneuploidy - in humans. Am. J. Hum. Genet., 64, 1702-1708.
12. Caron, H., van Schaik, B., van der Mee, M., Baas, F., Riggins, G., van Sluis, P., Hermus, M.C., van Asperen, R., Boon, K., Voute, P.A. et al. (2001) The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science, 291, 1289-1292.
13. Fuentes, J.J., Genesca, L., Kingsbury, T.J., Cunningham, K.W., Perez-Riba, M., Estivill, X. and de la Luna, S. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum. Mol. Genet., 9, 1681-1690.
14. Pucharcos, C., Fuentes, J.J., Casas, C., de la Luna, S., Alcantara, S., Arbones, M.L., Soriano, E., Estivill, X. and Pritchard, M. (1999) Alu-splice cloning of human Intersectin (ITSN), a putative multivalent binding protein expressed in proliferating and differentiating neurons and overexpressed in Down syndrome. Eur J. Hum. Genet., 7, 704-712.
15. Blouin, J.L., Duriaux Sail, G. and Antonarakis, S.E. (1996) Mapping of the human holocarboxylase synthetase gene (HCS) to the Down syndrome critical region of chromosome 21q22. Ann. Genet., 39, 185-188.
16. Blouin, J.L., Duriaux-Sail, G., Chen, H., Gos, A., Morris, M.A., Rossier, C. and Antonarakis, S.E. (1996) Mapping of the gene for the p60 subunit of the human chromatin assembly factor (CAF1A) to the Down syndrome region of chromosome 21. Genomics, 33, 309-312.
17. De La Torre, R., Casado, A., Lopez-Fernandez, E., Carrascosa, D., Ramirez, V. and Saez, J. (1996) Overexpression of copper-zinc superoxide dismutase in trisomy 21. Experientia, 52, 871-873.
18. Eki, T. Abe, M., Naitou, M., Sasanuma, S.I., Nohata, J., Kawashima, K., Ahmad, I., Hanaoka, F. and Murakami, Y. (1997) Cloning and characterization of novel gene, DCRR1, expressed from Down's syndrome critical region of human chromosome 21q22.2. DNA Seq., 7, 153-164.
19. Barlow, G.M., Chen, X.N., Shi, Z.Y., Lyons, G.E., Kurnit, D.M., Celle, L., Spinner, N.B., Zackai, E., Pettenati, M.J., Van Riper, A.J. et al. (2001) Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med., 3, 91-101.
20. Marks, A. and Allore, R. (1990) S100 protein and Down syndrome. Bioessays, 12, 381-383.
21. Krapfenbauer, K., Yoo, B.C., Kim, S.H., Cairns, N. and Lubec, G. (2001) Differential display reveals downregulation of the phospholipid transfer protein (PLTP) at the mRNA level in brains of patients with Down syndrome. Life Sci., 68, 2169-2179.
22. Labudova, O., Kitzmueller, E., Rink, H., Cairns, N. and Lubec, G. (1999) Gene expression in fetal Down syndrome brain as revealed by subtractive hybridization. J. Neural. Transm., 57 (Suppl.), 125-136.
23. Chrast, R., Scott, H.S., Papasawas, M.P., Rossier, C., Antonarakis, E.S., Barras, C., Davisson, M.T., Schmidt, C., Estivill, X., Dierssen, M. et al. (2000) The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res., 10, 2006-2021.
24. Komatsu, T., Kubota, E. and Sakai, N. (2001) Enhancement of matrix metalloproteinase (MMP)-2 activity in gingival tissue and cultured fibroblasts from Down's syndrome patients. Oral Dis., 7, 47-55.
25. Halinen, S., Sorsa, T., Ding, Y., Ingman, T., Salo, T., Konttinen, Y.T. and Saari, H. (1996) Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. J Periodontol., 67, 748-754.
26. Miyazaki, K. Hasegawa, M., Funahashi, K. and Umeda, M. (1993) A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor. Nature, 362, 839-841.
27. Papastoitsis, G., Siman, R., Scott, R. and Abraham, C.R. (1994) Identification of a metalloprotease from Alzheimer's disease brain able to degrade the beta-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry, 33, 192-199.
28. Waterham, H.R., Koster, J., Romeijn, G.J., Hennekam, R.C., Vreken, P., Andersson, H.C., FitzPatrick, D.R., Kelly, R.I. and Wanders, R.J. (2001) Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet., 69, 685-694.
29. Kelley, R.L., Roessler, E., Hennekam, R.C., Feldman, G.L., Kosaki, K., Jones, M.C., Palumbos, J.C. and Muenke, M. (1996) Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am. J. Med. Genet., 66, 478-484.
30. Muenke, M. and Cohen, M.M., Jr. (2000) Genetic approaches to understanding brain development: holoprosencephaly as a model. Ment. Retard. Dev. Disabil. Res. Rev., 6, 15-21.
31. Gardiner, K. and Davisson, M. (2000) The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol., 1, 1-9.
32. Eggert, A., Brodeur, G.M. and Ikegaki, N. (2000) Relative quantitative RT-PCR protocol for TrkB expression in neuroblastoma using GAPD as an internal control. Biotechniques, 28, 681-682, 686, 688-691.
33. Bushman, T.L. and Kuemmerle, J.F. (1998) IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta1. Am. J. Physiol., 275, G1282-1290.
34. Pfaffl, M.W. (2001) Development and validation of an externally standardised quantitative insulin like growth factor-1 (IGF-1) RT-PCR using LightCycler SYBR® Green I technology. In Meuer, S. Wittwer, C. and Nakagawara, K. (eds), Rapid Cycle Real-time PCR, Methods and Applications, Springer Press, Heidelberg, pp. 281-291.